byMediaBoost

TECregen

Raised $12.5M in a Seed round, announced 8 January 2026.

Total raised
$12.5M

Latest round SeedCountry SwitzerlandSector Health

Round

$12.5MSeed, 8 January 2026

Funds thymopoietic biologics toward the clinic; Dr. Bo Rode Hansen named chairman.

Amount
$12.5M
Stage
Seed
Announced
8 January 2026
Lead
Boehringer Ingelheim Venture Fund
Other investors
LifeSpan Vision Ventures, Carma Fund, EOS BioInnovation, HTGF, Zurich Cantonal Bank
Use of funds
Funds thymopoietic biologics toward the clinic; Dr. Bo Rode Hansen named chairman.
Checked
Announced by the company
Sources
TECregen Raises CHF 10 Million Seed Round, Names Dr. Bo Rode Hansen Chairman htgf.de
TECregen Raises CHF 10 Million Seed Round, Names Dr. Bo Rode Hansen Chairman pulse2.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Biologics to regenerate the thymus and restore T-cell immunity

Based in
Basel, Switzerland
Sector
Health

Questions

How much has TECregen raised?

TECregen raised $12.5M in a Seed round, announced on 8 January 2026.

Who invested in TECregen?

Boehringer Ingelheim Venture Fund led. Investors include Boehringer Ingelheim Venture Fund, LifeSpan Vision Ventures, Carma Fund, EOS BioInnovation, HTGF and Zurich Cantonal Bank.